Related Experiment Video
Updated: Aug 8, 2026
10:32
Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Published on: June 17, 2013
Parasympathetic assessment in Parkinson's disease
Advances in Neurology
|January 1, 1987
Summary
Early Parkinson's disease (PD) patients show subtle autonomic dysfunction, specifically parasympathetic impairment. This finding suggests central nervous system involvement, independent of disease stage or treatment.
Area of Science:
- Neurology
- Autonomic Neuroscience
Background:
- Autonomic dysfunction is a recognized, yet understudied, aspect of Parkinson's disease (PD).
- Limited data exists on autonomic function in de novo PD patients, especially those without confounding conditions.
Purpose of the Study:
- To investigate autonomic nervous system function in de novo Parkinson's disease patients.
- To identify early signs of autonomic dysfunction in mild PD stages.
Main Methods:
- Studied 14 de novo PD patients (mild stage) and 14 age/sex-matched controls.
- Assessed autonomic function through respiratory sinus arrhythmias during deep and quiet breathing, and Valsalva ratios.
- Excluded participants with diabetes, heart disease, alcoholism, neuropathy, or orthostatic hypotension.
Main Results:
- A statistically significant difference in respiratory sinus arrhythmias during deep breathing was observed (p < 0.01).
- No significant differences were found in basal heart rate, respiratory sinus arrhythmias during quiet breathing, or Valsalva ratios.
- The identified abnormality suggests parasympathetic dysfunction, potentially central, in early PD.
Conclusions:
- Early-stage Parkinson's disease is associated with specific parasympathetic nervous system abnormalities.
- These autonomic changes appear independent of disease severity and therapeutic interventions.
- Findings suggest a potential central origin for early autonomic dysfunction in PD.
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...